Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Contracts Finder |
| Notice Type: | Award notice |
| Buyer: | NHS england |
| Main Category: | Goods |
| Procurement Method: | Open procedure (above threshold) |
| Tender Status: | Closed |
| Estimated Value (ex. VAT): |
Awarded to (30 suppliers)
Invitation to offer for NHS National Generics Pharmaceuticals Transition 2023_1 Offer reference number: CM/PHG/22/5666 FIND A TENDER (FTS) Reference number: 2023/S 000-000801 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 18 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months. CM/PHG/22/5666/00 - Transition Products: CESW 01/08/2023 - 31/01/2024 (6 months) NWLN 01/08/2023 - 31/01/2025 (18 months) LSNE 01/08/2023 - 31/05/2024 (10 months) CM/PHG/22/5666/01 - Orals (plus non-parenteral) Products: All regions: 01/08/2023 to 31/05/2024 (10 Months)
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Application Deadline
17 February 2023
Closed
Estimated Value
£99,290,712
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| £99,290,712 |
| Release Date: | 24 May 2023 |
| Application Deadline: | 17 February 2023 |
| Contract Start Date: | 31 July 2023 |
| Contract End Date: | 31 January 2025 |
| Contract Duration: | 1.5 years |
| Procurement ID (OCID): | ocds-b5fd17-1b88b5ed-794a-4149-937c-9ac69f636a09 |
| Notice Reference: | 82b7505c-e6e7-47d8-bb19-a1290cc3a40d-647947 |
View Original Notice
Access the full notice on the official portal
| Award value: | £57,604,995 |
| Award decision date: | 4 May 2023 |
| Award status: | Active |